Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.
Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Nadlaou SD, Dean NE, Diallo A, Diallo A, Honora DA, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, Riveros X, Oumar FT, Fallah M, Toure A, Vicari AS, Longini IM, Edmunds WJ, Henao-Restrepo AM, Kieny MP, Kéïta S. Gsell PS, et al. Lancet Infect Dis. 2017 Dec;17(12):1276-1284. doi: 10.1016/S1473-3099(17)30541-8. Epub 2017 Oct 9. Lancet Infect Dis. 2017. PMID: 29033032 Free PMC article.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. Henao-Restrepo AM, et al. Among authors: gsell ps. Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Lancet. 2017. PMID: 28017403 Free PMC article. Clinical Trial.
Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic.
Robert A, Edmunds WJ, Watson CH, Henao-Restrepo AM, Gsell PS, Williamson E, Longini IM, Sakoba K, Kucharski AJ, Touré A, Nadlaou SD, Diallo B, Barry MS, Fofana TO, Camara L, Kaba IL, Sylla L, Diaby ML, Soumah O, Diallo A, Niare A, Diallo A, Eggo RM. Robert A, et al. Among authors: gsell ps. Am J Epidemiol. 2019 Jul 1;188(7):1319-1327. doi: 10.1093/aje/kwz090. Am J Epidemiol. 2019. PMID: 30941398 Free PMC article.
Design of vaccine efficacy trials during public health emergencies.
Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. Dean NE, et al. Among authors: gsell ps. Sci Transl Med. 2019 Jul 3;11(499):eaat0360. doi: 10.1126/scitranslmed.aat0360. Sci Transl Med. 2019. PMID: 31270270 Free PMC article. Review.
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.
Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. Dean NE, et al. Among authors: gsell ps. N Engl J Med. 2020 Apr 2;382(14):1366-1369. doi: 10.1056/NEJMsb1905390. N Engl J Med. 2020. PMID: 32242365 Free PMC article. No abstract available.
Electronic Data Management for Vaccine Trials in Low Resource Settings: Upgrades, Scalability, and Impact of ODK.
Marks M, Lal S, Brindle H, Gsell PS, MacGregor M, Stott C, van de Rijdt M, Almazor GG, Golia S, Watson C, Diallo A, Toure A, Houlihan C, Keating P, Martin H, Restrepo AH, Anokwa Y, Roberts CH. Marks M, et al. Among authors: gsell ps. Front Public Health. 2021 Nov 4;9:665584. doi: 10.3389/fpubh.2021.665584. eCollection 2021. Front Public Health. 2021. PMID: 34805059 Free PMC article.
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in Guinea.
Robert A, Tsui Lok Hei J, Watson CH, Gsell PS, Hall Y, Rambaut A, Longini IM Jr, Sakoba K, Kucharski AJ, Touré A, Danmadji Nadlaou S, Saidou Barry M, Fofana TO, Lansana Kaba I, Sylla L, Diaby ML, Soumah O, Diallo A, Niare A, Diallo A, Eggo RM, Caroll MW, Henao-Restrepo AM, Edmunds WJ, Hué S. Robert A, et al. Among authors: gsell ps. Virus Evol. 2023 Mar 7;9(1):vead007. doi: 10.1093/ve/vead007. eCollection 2023. Virus Evol. 2023. PMID: 36926449 Free PMC article.
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).
Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM. Watson CH, et al. Among authors: gsell ps. BMC Med. 2024 Nov 7;22(1):523. doi: 10.1186/s12916-024-03726-z. BMC Med. 2024. PMID: 39511527 Free PMC article.
15 results